Sueca

Researchers are evaluating a continuity of care intervention aimed at improving metabolic control in adults with type 2 diabetes mellitus T2DM in the Terres de lEbre health region. This randomized, parallel-group clinical trial is led by the Endocrinology Service at Hospital de Tortosa Verge de la Cinta and focuses on training primary care professionals through structured, multidisciplinary education and feedback. The study addresses challenges in managing T2DM including glycemic control and cardiovascular risk, with HbA1c as the primary marker. The intervention involves onsite training sessions delivered by endocrinologists and nurse educators to primary care physicians and nurses at selected centers. Training consists of six modules combining theoretical and practical content related to diabetes management, cardiovascular risk reduction, and diabetic foot care. These sessions occur biweekly over one year from July 2025 to July 2026, with each participating center receiving 15 sessions. Centers are randomized to either receive this training or continue usual care without the specific continuity-of-care training. Participants with T2DM will be assessed at baseline, 6, 12, and 24 months for HbA1c and secondary health outcomes like cholesterol levels, blood pressure, BMI, and adherence to screening protocols. The study also collects professional feedback through focus groups before and after the intervention to understand barriers and facilitators. Data are anonymized, and the study aims to provide evidence on the effectiveness of multidisciplinary care continuity in a primary care setting over a two-year follow-up period.